OA10986A - Crystalline pharmaceutical product - Google Patents

Crystalline pharmaceutical product Download PDF

Info

Publication number
OA10986A
OA10986A OA9900047A OA9900047A OA10986A OA 10986 A OA10986 A OA 10986A OA 9900047 A OA9900047 A OA 9900047A OA 9900047 A OA9900047 A OA 9900047A OA 10986 A OA10986 A OA 10986A
Authority
OA
OAPI
Prior art keywords
tetrahydro
oxo
hydrochloride
benzodiazepine
carbonyl
Prior art date
Application number
OA9900047A
Other languages
English (en)
Inventor
Stephen Torey Ross
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of OA10986A publication Critical patent/OA10986A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
OA9900047A 1996-09-03 1999-03-03 Crystalline pharmaceutical product OA10986A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03

Publications (1)

Publication Number Publication Date
OA10986A true OA10986A (en) 2003-03-04

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900047A OA10986A (en) 1996-09-03 1999-03-03 Crystalline pharmaceutical product

Country Status (32)

Country Link
US (1) US6335330B1 (fr)
EP (1) EP0964684B1 (fr)
JP (1) JP2000517342A (fr)
CN (1) CN1102391C (fr)
AP (1) AP9901472A0 (fr)
AR (1) AR008154A1 (fr)
AT (1) ATE245984T1 (fr)
AU (1) AU731173B2 (fr)
BG (1) BG103196A (fr)
BR (1) BR9711981A (fr)
CA (1) CA2264607A1 (fr)
CO (1) CO4930262A1 (fr)
CZ (1) CZ71999A3 (fr)
DE (1) DE69723873T2 (fr)
DZ (1) DZ2302A1 (fr)
EA (1) EA001363B1 (fr)
ES (1) ES2205254T3 (fr)
HU (1) HUP9904077A3 (fr)
ID (1) ID18156A (fr)
IL (1) IL128782A0 (fr)
MA (1) MA24309A1 (fr)
MY (1) MY118175A (fr)
NO (1) NO991013D0 (fr)
NZ (1) NZ334438A (fr)
OA (1) OA10986A (fr)
PE (1) PE107198A1 (fr)
PL (1) PL332006A1 (fr)
SK (1) SK27699A3 (fr)
TR (1) TR199900480T2 (fr)
UY (1) UY24690A1 (fr)
WO (1) WO1998009629A1 (fr)
ZA (1) ZA977870B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
EP1443963B1 (fr) 2001-10-22 2014-05-21 The Scripps Research Institute Composes de ciblage d'anticorps
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
JP2012517447A (ja) 2009-02-10 2012-08-02 ザ スクリプス リサーチ インスティチュート 化学的にプログラムされたワクチン接種法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
US5693636A (en) 1991-06-28 1997-12-02 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ES2197160T3 (es) 1992-12-21 2004-01-01 Smithkline Beecham Corp Antagonistas fibronogeno bicicliclos.
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
SK27699A3 (en) 2000-02-14
EA199900260A1 (ru) 1999-08-26
IL128782A0 (en) 2000-01-31
EP0964684B1 (fr) 2003-07-30
AP9901472A0 (en) 1999-03-31
BR9711981A (pt) 1999-08-24
NO991013L (no) 1999-03-02
CN1102391C (zh) 2003-03-05
DE69723873D1 (de) 2003-09-04
CZ71999A3 (cs) 1999-08-11
ATE245984T1 (de) 2003-08-15
MY118175A (en) 2004-09-30
BG103196A (en) 1999-09-30
HUP9904077A3 (en) 2002-03-28
ID18156A (id) 1998-03-05
AR008154A1 (es) 1999-12-09
CN1234739A (zh) 1999-11-10
US6335330B1 (en) 2002-01-01
NZ334438A (en) 2000-10-27
ES2205254T3 (es) 2004-05-01
UY24690A1 (es) 1998-02-27
JP2000517342A (ja) 2000-12-26
HUP9904077A2 (hu) 2000-05-28
CO4930262A1 (es) 2000-06-27
DE69723873T2 (de) 2004-04-22
MA24309A1 (fr) 1998-04-01
NO991013D0 (no) 1999-03-02
TR199900480T2 (xx) 1999-06-21
EP0964684A4 (fr) 2002-05-29
AU4242597A (en) 1998-03-26
DZ2302A1 (fr) 2002-12-28
PE107198A1 (es) 1999-03-21
EA001363B1 (ru) 2001-02-26
CA2264607A1 (fr) 1998-03-12
PL332006A1 (en) 1999-08-16
WO1998009629A1 (fr) 1998-03-12
AU731173B2 (en) 2001-03-22
EP0964684A1 (fr) 1999-12-22
ZA977870B (en) 1998-03-03

Similar Documents

Publication Publication Date Title
CA2627086C (fr) Nouveaux sels pharmaceutiques et polymorphes d'un inhibiteur du facteur xa
CA2810004C (fr) Formes cristallines d'un inhibiteur du facteur xa
HUT74103A (en) Aroyl-piperidine derivative
EP0964684B1 (fr) Produit pharmaceutique cristallin
CN101516833A (zh) 用作凝血因子IXa抑制剂的酒石酸衍生物
PT770082E (pt) Derivados de acido dioxo-tiopirano-piridinocarboxilico e sua utilizacao como medicamentos
JP2000512648A (ja) ピペリジン酢酸誘導体および血栓障害の治療におけるそれらの使用
WO2019001307A1 (fr) Composé amide, composition le contenant, et utilisation associée
KR20140022851A (ko) 오타믹사반의 벤조산염
MXPA99002118A (en) Crystalline pharmaceutical product
KR20000068406A (ko) 결정질 제약 물질
JPH03118371A (ja) イミダゾール化合物及びトランスグルタミナーゼ阻害剤としてのその使用
SG190072A1 (en) Organic amine salts of aminobenzoic acid derivatives and method for producing same
HK1115131B (en) Pharmaceutical salts and polymorphs of n-(5-chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxy-benzamide , a factor xa inhibitor